首页> 外国专利> Substituted amides, pharmaceutical compositions containing them, a method for inhibiting ATP hydrolysis, METHOD FOR INHIBITING ACTIVITY OF B-CELLS, METHOD FOR DETERMINING Btk in a sample, method of treating diseases responsive to inhibition of Btk ACTIVITY, AND METHOD FOR INCREASING THE SENSITIVITY OF CANCER CELLS TO CHEMOTHERAPY

Substituted amides, pharmaceutical compositions containing them, a method for inhibiting ATP hydrolysis, METHOD FOR INHIBITING ACTIVITY OF B-CELLS, METHOD FOR DETERMINING Btk in a sample, method of treating diseases responsive to inhibition of Btk ACTIVITY, AND METHOD FOR INCREASING THE SENSITIVITY OF CANCER CELLS TO CHEMOTHERAPY

机译:取代的酰胺,包含它们的药物组合物,抑制ATP水解的方法,抑制B细胞活性的方法,测定样品中Btk的方法,治疗对Btk活性有抑制作用的疾病的方法以及提高其敏感性的方法化疗细胞

摘要

1. Substituted amides covered by the general Formula 1:! ! where R is an optionally substituted aryl or optionally substituted heteroaryl,! R4 is selected from the group consisting of hydrogen, optionally substituted lower alkyl, optionally substituted lower alkoxy, halogen and hydroxy,! R21 and R22 are independently selected from hydrogen and optionally substituted lower alkyl,! R16 is selected from the group consisting of hydrogen, cyano, optionally substituted cycloalkyl and optionally substituted lower alkyl,! And selected from the group consisting of optionally substituted 5-membered heteroaryl, optionally substituted pyridazinyl, optionally substituted pyrimidinyl and optionally substituted pyrazinyl,! L is selected from the group consisting of optionally substituted C0-C4 alkylene, -O-optionally substituted C0-C4 alkylene, - (C0-C4 alkylene) (SO) -, - (C0-C4 alkylene) (SO2) - and - (C0-C4 alkylene) ( C = O) -, ah! G is selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitro, optionally substituted alkyl, optionally substituted amino, optionally substituted carbamimidoyl, optionally substituted heterocycloalkyl, optionally substituted cycloalkyl, optionally substituted aryl and optionally substituted heteroaryl; ! and their pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs and mixtures. ! 2. The substituted amides according to claim 1, in which R is selected from the group consisting of optionally mono-, di- or tri-substituted 4,5,6,7-tetrahydrobenzo [b] thiophen-2-yl, where the substituents are independently selected from lower alkyl, optionally mono-, di- or tri-substituted 5,6,7,8-tetrahydro-4H-cyclohepta [b] thiophen-2-yl, where the substituents are independently selected
机译:1.通式1涵盖的取代酰胺:! !其中R是任选取代的芳基或任选取代的杂芳基, R 4选自氢,任选取代的低级烷基,任选取代的低级烷氧基,卤素和羟基。 R 21和R 22独立地选自氢和任选取代的低级烷基! R 16选自氢,氰基,任选取代的环烷基和任选取代的低级烷基!并且选自任选取代的5元杂芳基,任选取代的哒嗪基,任选取代的嘧啶基和任选取代的吡嗪基。 L选自:任选取代的C 0 -C 4亚烷基,-O-任选取代的C 0 -C 4亚烷基,-(C 0 -C 4亚烷基)(SO)-,-(C 0 -C 4亚烷基)(SO 2)-和- (C0-C4亚烷基)(C = O)-啊! G选自氢,卤素,羟基,烷氧基,硝基,任选取代的烷基,任选取代的氨基,任选取代的脲基,任选取代的杂环烷基,任选取代的环烷基,任选取代的芳基和任选取代的杂芳基; !及其药学上可接受的盐,溶剂化物,螯合物,非共价复合物,前药和混合物。 ! 2.根据权利要求1的取代的酰胺,其中R选自任选地被单,二或三取代的4,5,6,7-四氢苯并[b]噻吩-2-基组成的组,其中取代基独立地选自低级烷基,任选地是单取代,二取代或三取代的5,6,7,8-四氢-4H-环庚[b]噻吩-2-基,其中取代基是独立选择的

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号